Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients
Clinical trial NCT03339102 · COMPLETED
Trial details
- NCT number
- NCT03339102
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-25
- Primary completion
- 2020-07-16
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.